Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-12-13 Sale |
2023-12-15 5:01 pm |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
21,262 | $65 | $1,382,030 | 0 (Direct) |
View |
| 2023-11-13 Sale |
2023-11-14 5:33 pm |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
50,000 | $53.9 | $2,694,783 | 46,115 (Direct) |
View |
| 2023-11-06 Sale |
2023-11-08 5:31 pm |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
42,393 | $55.63 | $2,358,152 | 29,700 (Direct) |
View |
| 2023-09-18 Sale |
2023-09-19 8:40 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
100,000 | $53.94 | $5,394,065 | 1,050,309 (Direct) |
View |
| 2023-08-07 Sale |
2023-08-09 6:05 pm |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
55,300 | $58.79 | $3,251,087 | 45,339 (Direct) |
View |
| 2023-07-17 Sale |
2023-07-20 5:47 pm |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
1,842 | $65 | $119,730 | 21,262 (Direct) |
View |
| 2023-06-14 Sale |
2023-06-16 5:05 pm |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
81,854 | $63.97 | $5,236,329 | 14,960 (Direct) |
View |
| 2023-04-17 Sale |
2023-04-19 6:00 pm |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
10,000 | $63 | $630,000 | 9,345 (Direct) |
View |
| 2023-03-28 Sale |
2023-03-30 5:08 pm |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
15,604 | $54.31 | $847,380 | 45,339 (Direct) |
View |
| 2023-03-13 Sale |
2023-03-13 7:36 pm |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
7,344 | $45.04 | $330,794 | 37,794 (Direct) |
View |
| 2023-03-10 Sale |
2023-03-13 7:35 pm |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
12,308 | $43.84 | $539,599 | 75,633 (Direct) |
View |
| 2023-03-10 Sale |
2023-03-13 7:34 pm |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
24,052 | $43.66 | $1,050,092 | 14,690 (Direct) |
View |
| 2023-03-10 Sale |
2023-03-13 7:32 pm |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
21,245 | $43.55 | $925,225 | 11,164 (Direct) |
View |
| 2023-03-10 Sale |
2023-03-13 7:31 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
62,335 | $43.76 | $2,727,841 | 1,191,440 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-03 7:03 pm |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
7,241 | $50.01 | $362,122 | 49,199 (Direct) |
View |
| 2023-02-24 Sale |
2023-02-27 8:03 pm |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
4,046 | $47.12 | $190,648 | 64,347 (Direct) |
View |
| 2023-02-24 Sale |
2023-02-27 8:02 pm |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. SVP, Chief Medical Officer |
7,906 | $47.14 | $372,689 | 31,011 (Direct) |
View |
| 2023-02-24 Sale |
2023-02-27 8:01 pm |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
7,906 | $47.03 | $371,819 | 7,907 (Direct) |
View |
| 2023-02-24 Sale |
2023-02-27 8:00 pm |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
7,455 | $47.03 | $350,609 | 7,455 (Direct) |
View |
| 2023-02-24 Sale |
2023-02-27 7:59 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
22,590 | $47.03 | $1,062,408 | 1,172,899 (Direct) |
View |
| 2023-02-21 Sale |
2023-02-22 8:05 pm |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
3,898 | $47.01 | $183,246 | 52,580 (Direct) |
View |
| 2023-02-21 Sale |
2023-02-22 8:04 pm |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. SVP, Chief Medical Officer |
8,354 | $46.84 | $391,304 | 23,104 (Direct) |
View |
| 2023-02-21 Sale |
2023-02-22 8:03 pm |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
11,139 | $46.84 | $521,699 | 0 (Direct) |
View |
| 2023-02-17 Sale |
2023-02-22 8:02 pm |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
64,411 | $49.34 | $3,178,354 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-12-31 Option Award |
2024-01-03 6:43 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
76 | $71.62 | 9,611 (Direct) |
View |
| 2023-11-13 Exercise |
2023-11-14 5:33 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
15,164 | $15.47 | 46,115 (Direct) |
View |
| 2023-11-13 Exercise |
2023-11-14 5:33 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
34,836 | $12.73 | 46,115 (Direct) |
View |
| 2023-11-13 Exercise |
2023-11-14 5:33 pm |
N/A 2028-01-03 |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
50,000 | $0 | 46,115 (Direct) |
View |
| 2023-11-06 Exercise |
2023-11-08 5:31 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
26,754 | $23.94 | 29,700 (Direct) |
View |
| 2023-11-06 Exercise |
2023-11-08 5:31 pm |
N/A 2030-02-17 |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
26,754 | $0 | 29,700 (Direct) |
View |
| 2023-09-30 Option Award |
2023-10-02 5:30 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
105 | $52.09 | 9,535 (Direct) |
View |
| 2023-09-30 Option Award |
2023-10-02 5:29 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
345 | $52.09 | 78,984 (Direct) |
View |
| 2023-08-07 Exercise |
2023-08-09 6:05 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
55,300 | $18.59 | 45,339 (Direct) |
View |
| 2023-08-07 Exercise |
2023-08-09 6:05 pm |
N/A 2028-10-14 |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
55,300 | $0 | 45,339 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 4:30 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
279 | $63.32 | 78,639 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 4:29 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
85 | $63.32 | 9,430 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 5:12 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
8,576 | $0 | 8,576 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 5:12 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Salas Eduardo Rene Director |
8,576 | $0 | 8,576 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 5:11 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
8,576 | $0 | 8,576 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 5:11 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
8,576 | $0 | 8,576 (Direct) |
View |
| 2023-06-14 Exercise |
2023-06-16 5:05 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
25,082 | $23.94 | 14,960 (Direct) |
View |
| 2023-06-14 Exercise |
2023-06-16 5:05 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
11,762 | $36.89 | 14,960 (Direct) |
View |
| 2023-06-14 Exercise |
2023-06-16 5:05 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
4,538 | $56.73 | 14,960 (Direct) |
View |
| 2023-06-14 Exercise |
2023-06-16 5:05 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
40,472 | $53.63 | 14,960 (Direct) |
View |
| 2023-06-14 Exercise |
2023-06-16 5:05 pm |
N/A 2026-01-03 |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
81,854 | $0 | 14,960 (Direct) |
View |
| 2023-04-17 Exercise |
2023-04-19 6:00 pm |
N/A 2029-06-24 |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
10,000 | $0 | 9,345 (Direct) |
View |
| 2023-04-17 Exercise |
2023-04-19 6:00 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
10,000 | $13.05 | 9,345 (Direct) |
View |
| 2023-03-31 Option Award |
2023-04-04 5:03 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
95 | $54.15 | 9,345 (Direct) |
View |
| 2023-03-31 Option Award |
2023-04-04 5:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
313 | $54.15 | 78,360 (Direct) |
View |
| 2023-03-10 Exercise |
2023-03-13 7:36 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
7,344 | $0 | 37,794 (Direct) |
View |
| 2023-03-09 Option Award |
2023-03-13 7:35 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
16,708 | $0 | 75,633 (Direct) |
View |
| 2023-03-10 Exercise |
2023-03-13 7:35 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
7,344 | $0 | 75,633 (Direct) |
View |
| 2023-03-09 Option Award |
2023-03-13 7:34 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
16,708 | $0 | 14,690 (Direct) |
View |
| 2023-03-10 Exercise |
2023-03-13 7:34 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
7,344 | $0 | 14,690 (Direct) |
View |
| 2023-03-09 Option Award |
2023-03-13 7:32 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
15,663 | $0 | 11,164 (Direct) |
View |
| 2023-03-10 Exercise |
2023-03-13 7:32 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
5,582 | $0 | 11,164 (Direct) |
View |
| 2023-03-09 Option Award |
2023-03-13 7:31 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
41,770 | $0 | 1,191,440 (Direct) |
View |
| 2023-03-13 Exercise |
2023-03-13 7:31 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
20,000 | $3.26 | 1,191,440 (Direct) |
View |
| 2023-03-10 Exercise |
2023-03-13 7:31 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
40,565 | $0 | 1,191,440 (Direct) |
View |
| 2023-03-06 Option Award |
2023-03-08 7:54 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
39,398 | $0 | 39,398 (Direct) |
View |
| 2023-03-06 Option Award |
2023-03-08 7:52 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
39,398 | $0 | 39,398 (Direct) |
View |
| 2023-03-06 Option Award |
2023-03-08 7:51 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
39,398 | $0 | 39,398 (Direct) |
View |
| 2023-03-06 Option Award |
2023-03-08 7:50 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
39,398 | $0 | 39,398 (Direct) |
View |
| 2023-03-06 Option Award |
2023-03-08 7:49 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
122,137 | $0 | 122,137 (Direct) |
View |
| 2023-02-23 Exercise |
2023-02-27 8:03 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
7,906 | $0 | 64,347 (Direct) |
View |
| 2023-02-23 Exercise |
2023-02-27 8:02 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. SVP, Chief Medical Officer |
7,906 | $0 | 31,011 (Direct) |
View |
| 2023-02-23 Exercise |
2023-02-27 8:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
7,906 | $0 | 7,907 (Direct) |
View |
| 2023-02-23 Exercise |
2023-02-27 8:00 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
7,455 | $0 | 7,455 (Direct) |
View |
| 2023-02-24 Exercise |
2023-02-27 7:59 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
30,000 | $3.26 | 1,172,899 (Direct) |
View |
| 2023-02-23 Exercise |
2023-02-27 7:59 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
52,590 | $0 | 1,172,899 (Direct) |
View |
| 2023-02-18 Exercise |
2023-02-22 8:05 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
11,139 | $0 | 52,580 (Direct) |
View |
| 2023-02-18 Exercise |
2023-02-22 8:04 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. SVP, Chief Medical Officer |
8,354 | $0 | 23,104 (Direct) |
View |
| 2023-02-18 Exercise |
2023-02-22 8:03 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
11,139 | $0 | 0 (Direct) |
View |
| 2023-02-17 Exercise |
2023-02-22 8:02 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
53,968 | $12.73 | 0 (Direct) |
View |
| 2023-02-17 Exercise |
2023-02-22 8:02 pm |
N/A 2029-01-07 |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
64,411 | $0 | 0 (Direct) |
View |